Lilly raises full-year earnings forecasts on surging demand for weight-loss drug – Reuters
- Lilly raises full-year earnings forecasts on surging demand for weight-loss drug Reuters
- Lilly reports second-quarter 2025 financial results and raises guidance | Eli Lilly and Company Eli Lilly
- Eli Lily Q2 Earnings Preview: Future Depends on Mounjaro and Zepbound Performance Investing.com
- These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings CNBC
- Eli Lilly beats earnings for second quarter on strong GLP-1 sales, but stock dives on GLP-1 pill trial results Yahoo Finance